We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Can We Stem the Tide of Unsuccessful Drugs?

Article   Feb 11, 2019 | by Alexandra Boussommier-Calleja

 
Pluripotent Stem Cells in Drug Discovery: Can We Stem the Tide of Unsuccessful Drugs?
 
 
 

RELATED ARTICLES

The Genetics of Neurodegeneration With Professor John Hardy

Article

At the British Neuroscience Association (BNA)’s Festival of Neuroscience in April 2019, we were lucky enough to sit down with some influential neuroscientists to discuss their work. Here we interview University College London’s John Hardy, whose work into the genetics of neurodegenerative disorders saw him share the Brain Prize in 2018.

READ MORE

Gram Positive vs Gram Negative

Article

Being able to differentiate bacterial species is important for a host of reasons. Whilst molecular techniques can determine the specific species, even without getting into the molecular nitty gritty, there are phenotypic differences between groups of bacteria that can be used to differentiate them. One such useful classification – if a bacterium is Gram positive or Gram negative - is based on the structure of bacterial cell walls.

READ MORE

Gray Matter vs White Matter

Article

The brain is an immensely complex structure, but there are ways we can divide up its anatomical structure into more discrete parts. One common divider is to separate the brain’s gray and white matter. But what are these two structures? How different are they from each other? How significant, and physiologically relevant, is this divide?

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Genomics Research Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE